Scenarios that move HAIN
The Hain Celestial Group, Inc. - Common Stock
Scenarios that move HAIN: 1 analysis, 0 positive, 1 negative.
- · argenx meets primary endpoint in Phase II celiac disease study — ▼ · impact -8 · confidence low · horizon quarters
The Hain Celestial Group, Inc. - Common Stock
Scenarios that move HAIN: 1 analysis, 0 positive, 1 negative.